July 17, 2025 05:36 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Air India finds 'no issues' with fuel control switch on Boeing 787-8 planes after precautionary checks | Anchor runs mid-telecast as Israeli airstrikes hit Syria's state TV building | Rare oil painting of Mahatma Gandhi sells for an astounding Rs 1.7 crore | Brother of Yemeni man killed by Nimisha Priya opposes pardon of Kerala nurse | Can't win today's warfare with outdated weapons: CDS General Anil Chauhan seeks upgradation of India's defence system | Shubhanshu Shukla returns to Earth after his 18-day mission to space | India's Got Latent host Samay Raina, other influencers appear in SC over remarks mocking disabled | Drunk teenager who rammed Porsche into two-wheeler leaving two dead won't be tried as an adult | Jaishankar calls on China's President Xi Jinping in Beijing | Jaishankar calls on China's President Xi Jinping in Beijing
US FDA
Wallpaper Cave

US FDA adds warning on Johnson & Johnson COVID-19 vaccine related to rare neurological disorder

| @indiablooms | Jul 13, 2021, at 02:18 pm

Washington/UNI/Xinhua: The US Food and Drug Administration (FDA) added a new warning on the Johnson & Johnson COVID-19 vaccine, saying the vaccine has been linked to a serious but rare side effect called Guillain-Barre syndrome.

Guillain Barre syndrome is a neurological disorder in which the body's immune system damages nerve cells, causing muscle weakness and sometimes paralysis, the FDA said on Monday.

The syndrome has occurred in some people who have received the Johnson & Johnson vaccine. In most of these people, symptoms began within 42 days following injections of the vaccine, said the FDA in a letter.

The chance of having this occur is very low, the agency said.

About 100 preliminary reports of Guillain-Barre syndrome have been detected in vaccine recipients after the administration of 12.8 million doses of the Johnson & Johnson vaccine in the United States, The Washington Post quoted the U.S. Centers for Disease Control and Prevention (CDC) as saying in a statement.

Of these reports, 95 were serious and required hospitalization, and one was dead.

The cases have largely been reported about two weeks after vaccination and mostly in men, many aged 50 and older, according to the CDC.

Johnson & Johnson said Monday it has been in discussions with the FDA and other regulators about rare cases of Guillain-Barre syndrome.

The chance of having this occur is very low, and the rate of reported cases exceeds the background rate by a small degree, the company said in a statement.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.
Close menu